Contact Us

Phenylpropanolamine PPA
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Date you started taking this drug:

Date you stopped taking this drug:

State where drug was ingested:

What product(s) was/were used containing PPA?

Was the injury a stroke/brain hemorrhage?

What date did stroke or hemorrhage occur?

If yes, what type of stroke/brain hemorrhage was suffered?

If you checked Ischemic, did injured party have Atrial Fibrillation?

How many days after using the PPA product did injured party suffer the stroke/hemorrhage?

How often was this medication used and when was it last used?

Does injured party still have this medication?

What additional medications were you taking at the time?

Have you taken the diet drug Meridia?

Please describe any residual damages resulting from stroke (paralysis, slurred speech, memory loss):

If stroke was suffered, has any doctor given his/her opinion as to the cause of the stroke?

If injured party did NOT have a stroke, what injuries were suffered as a result of PPA?

Please further describe side effects:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Drug Agency Bans 167 Cold Medicines Over Stroke Risk

Aug 2, 2004 | The Korean Herald

The government ordered a ban on the prescription and manufacturing of cold medicines containing Phenylpropanolamine yesterday, citing risk of brain stroke, especially among women.

Nearly 170 medicines manufactured or imported by 75 companies are subject to the government interdiction, the Korea Food & Drug Administration said. The major companies included Yuhan Corporation, Choongwae Pharma Corp., Daewoong Co. and Hyundai Pharm.

PPA is an ingredient that was used in many over-the-counter and prescription cough and cold medications as a decongestant and in weight loss products.

At issue is hemorrhagic stroke, which causes bleeding into the brain or into tissue surrounding the brain.

The alleged relation of PPA and increased risk of hemorrhagic stroke is based on a recent government-commissioned examination of more than 900 local patients suffering from the disease, officials said.

In November 2000, after warnings by U.S. Food & Drug Administration, the government asked drug companies to voluntarily reformulate their products to exclude PPA. Some of drugmakers and import companies complied with the government recommendation but many of them did not.

Some local pharmaceutical companies reformulated their medicine exported to the United States but continued to manufacture PPA-containing medicine for the local market, a government official said.

Seventy-five drug import companies or manufacturers are banned from manufacturing, importing and shipping the cough medicines and required to take them off shelves and dispose them.

According to the U.S. FDA, taking PPA increases the risk of hemorrhagic stroke in women and men may also be at risk. Although the risk of hemorrhagic stroke is very low, KFDA recommended that consumers not use any products that contain PPA.

The drug companies may face a series of lawsuits by patients, consumer rights groups say.

"Those who took medicines containing PPA were twice more likely to suffer from hemorrhagic stroke than those who did not," said a Seoul National Univeristy professor who participated in the investigation.

A controversy over the ban is expected as some of the companies plan to raise objections to the KFDA study.

Crititcism of the KFDA also came from the general public. Many citizens criticized the KFDA for making the announcement on a weekend when people were less likelly to be paying attention to news developments.

They also said the government should have imposed a formal ban four years ago rather than request voluntary compliance that failed to adequately protect public health.

Related articles Other articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo